Publication Date:
1981-02-06
Description:
Arginine vasopressin and a number of its synthetic analogs augment memory functions in experimental animals. One of these analogs, 1-desamino-8-D-arginine vasopressin (DDAVP), influences human learning and memory. Cognitively unimpaired, as well as cognitively impaired adults, treated with DDAVP for a period of several days, learn information more effectively, as measured by the completeness, organization, and consistency (reliability) of recall. DDAVP also appears to reverse partially the retrograde amnesia that follows electroconvulsive treatment.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Weingartner, H -- Gold, P -- Ballenger, J C -- Smallberg, S A -- Summers, R -- Rubinow, D R -- Post, R M -- Goodwin, F K -- New York, N.Y. -- Science. 1981 Feb 6;211(4482):601-3.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/7455701" target="_blank"〉PubMed〈/a〉
Keywords:
Adult
;
Arginine Vasopressin/*pharmacology
;
Cognition/drug effects
;
Deamino Arginine Vasopressin/pharmacology
;
Depression/physiopathology
;
Female
;
Humans
;
Learning/*drug effects
;
Male
;
Memory/*drug effects
;
Middle Aged
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink
